Xin Jin1, Ru-huan Wang2, Hui Wang3, Chao-liang Long1, Hai Wang1,2. 1. Cardiovascular Drug Research Center, Institute of Health and Environmental Medicine, Academy of Military Medical Sciences, Beijing 100850, China. 2. Cardiovascular Drug Research Center, Thadweik Academy of Medicine, Beijing 100039, China. 3. Department of Neurosurgery, the 307 Hospital of PLA, Beijing 100071, China.
Abstract
AIM: To determine whether administration of choline could attenuate brain injury in a rat model of ischemic stroke and the underlying mechanisms. METHODS: A rat model of ischemic stroke was established through permanent middle cerebral artery occlusion (pMCAO). After the surgery, the rats were treated with choline or choline plus the specific α7 nAChR antagonist methyllycaconitine (MLA), or with the control drug nimodipine for 10 days. The neurological deficits, brain-infarct volume, pial vessel density and the number of microvessels in the cortex were assessed. Rat brain microvascular endothelial cells (rBMECs) cultured under hypoxic conditions were used in in vitro experiments. RESULTS: Oral administration of choline (100 or 200 mg·kg(-1)·d(-1)) or nimodipine (20 mg·kg(-1)·d(-1)) significantly improved neurological deficits, and reduced infarct volume and nerve cell loss in the ischemic cerebral cortices in pMCAO rats. Furthermore, oral administration of choline, but not nimodipine, promoted the pial arteriogenesis and cerebral-cortical capillary angiogenesis in the ischemic regions. Moreover, oral administration of choline significantly augmented pMCAO-induced increases in the expression levels of α7 nAChR, HIF-1α and VEGF in the ischemic cerebral cortices as well as in the serum levels of VEGF. Choline-induced protective effects were prevented by co-treatment with MLA (1 mg·kg(-1)·d(-1), ip). Treatment of rBMECs cultured under hypoxic conditions in vitro with choline (1, 10 and 100 μmol/L) dose-dependently promoted the endothelial-cell proliferation, migration and tube formation, as well as VEGF secretion, which were prevented by co-treatment with MLA (1 μmol/L) or by transfection with HIF-1α siRNA. CONCLUSION: Choline effectively attenuates brain ischemic injury in pMCAO rats, possibly by facilitating pial arteriogenesis and cerebral-cortical capillary angiogenesis via upregulating α7 nAChR levels and inducing the expression of HIF-1α and VEGF.
AIM: To determine whether administration of choline could attenuate brain injury in a rat model of ischemic stroke and the underlying mechanisms. METHODS: A rat model of ischemic stroke was established through permanent middle cerebral artery occlusion (pMCAO). After the surgery, the rats were treated with choline or choline plus the specific α7 nAChR antagonist methyllycaconitine (MLA), or with the control drug nimodipine for 10 days. The neurological deficits, brain-infarct volume, pial vessel density and the number of microvessels in the cortex were assessed. Rat brain microvascular endothelial cells (rBMECs) cultured under hypoxic conditions were used in in vitro experiments. RESULTS: Oral administration of choline (100 or 200 mg·kg(-1)·d(-1)) or nimodipine (20 mg·kg(-1)·d(-1)) significantly improved neurological deficits, and reduced infarct volume and nerve cell loss in the ischemic cerebral cortices in pMCAO rats. Furthermore, oral administration of choline, but not nimodipine, promoted the pial arteriogenesis and cerebral-cortical capillary angiogenesis in the ischemic regions. Moreover, oral administration of choline significantly augmented pMCAO-induced increases in the expression levels of α7 nAChR, HIF-1α and VEGF in the ischemic cerebral cortices as well as in the serum levels of VEGF. Choline-induced protective effects were prevented by co-treatment with MLA (1 mg·kg(-1)·d(-1), ip). Treatment of rBMECs cultured under hypoxic conditions in vitro with choline (1, 10 and 100 μmol/L) dose-dependently promoted the endothelial-cell proliferation, migration and tube formation, as well as VEGF secretion, which were prevented by co-treatment with MLA (1 μmol/L) or by transfection with HIF-1α siRNA. CONCLUSION:Choline effectively attenuates brain ischemic injury in pMCAO rats, possibly by facilitating pial arteriogenesis and cerebral-cortical capillary angiogenesis via upregulating α7 nAChR levels and inducing the expression of HIF-1α and VEGF.
Authors: Christopher Heeschen; Michael Weis; Alexandra Aicher; Stefanie Dimmeler; John P Cooke Journal: J Clin Invest Date: 2002-08 Impact factor: 14.808
Authors: Johannes Jacobi; James J Jang; Uma Sundram; Hayan Dayoub; Luis F Fajardo; John P Cooke Journal: Am J Pathol Date: 2002-07 Impact factor: 4.307
Authors: Jun Yu; Wei-Xing Zhao; Chun-Yan DU; Na Zhang; Wei-Dong Zhang; Sheng-Yang Jin; Hai Wang; Ze-Guo Feng Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2017-05-20
Authors: Eva Baranovicova; Petra Hnilicova; Dagmar Kalenska; Peter Kaplan; Maria Kovalska; Zuzana Tatarkova; Anna Tomascova; Jan Lehotsky Journal: Biomolecules Date: 2022-04-08
Authors: Eva Baranovicova; Marian Grendar; Dagmar Kalenska; Anna Tomascova; Daniel Cierny; Jan Lehotsky Journal: J Physiol Biochem Date: 2018-05-11 Impact factor: 4.158
Authors: Joon Ha Park; Ji Hyeon Ahn; Tae-Kyeong Lee; Cheol Woo Park; Bora Kim; Jae-Chul Lee; Dae Won Kim; Myoung Cheol Shin; Jun Hwi Cho; Choong-Hyun Lee; Soo Young Choi; Moo-Ho Won Journal: Mar Drugs Date: 2020-04-15 Impact factor: 5.118